Use of retinoic acid and analogs thereof to treat central neural apneas
US11045441B2 · kind B2 · utility
0Cited by
27References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 2016 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Oct 13, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described is a method of inhibiting central apnea, central hypopnea or obstructive sleep apnea in a mammal. The method includes the step of administering to a mammal a central apnea inhibitory-effective, central hypopnea inhibitory-effective or obstructive sleep apnea inhibitory-effective amount of a composition comprising at least one retinoid or retinoid or retinoic acid receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.